Prot# I5A-MC-JAEM: An Open-Label, Multicenter, Randomized, Phase 2 Study Evaluating the Safety and Efficacy of Cisplatin and Pemetrexed with or without Cixutumumab as First-Line Therapy in Patients with Advanced Nonsquamous Non-Small Cell Lung Carcinoma

  • Patel, Jyoti D (PD/PI)

Project: Research project

Project Details

Effective start/end date8/17/112/5/16


  • Lilly USA, LLC (I5A-MC-JAEM)